These findings suggest that TIMP2 serves not only as a biomarker but also as a potential therapeutic target for mitigating the AKI-CKD transition.<h4>Highlights</h4>TIMP2 is upregulated in injured renal tubules and promotes maladaptive repair and cell senescence. The gene discussed is TIMP2; the disease is acute kidney injury.